Focus Partners Advisor Solutions LLC raised its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 7.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,973 shares of the company’s stock after acquiring an additional 1,608 shares during the period. Focus Partners Advisor Solutions LLC’s holdings in Bath & Body Works were worth $688,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC increased its position in shares of Bath & Body Works by 38.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company’s stock valued at $1,265,000 after acquiring an additional 11,681 shares during the last quarter. IFM Investors Pty Ltd acquired a new stake in shares of Bath & Body Works during the first quarter valued at about $1,314,000. Golden State Wealth Management LLC increased its position in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock valued at $40,000 after acquiring an additional 642 shares during the last quarter. Amundi increased its position in shares of Bath & Body Works by 382.1% during the first quarter. Amundi now owns 174,951 shares of the company’s stock valued at $4,872,000 after acquiring an additional 138,664 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Bath & Body Works during the first quarter valued at about $23,273,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on BBWI shares. UBS Group dropped their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research report on Friday, August 29th. Citigroup lowered their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a research note on Tuesday, August 19th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $26.00 price objective on shares of Bath & Body Works in a research note on Monday, October 6th. Barclays lowered their price objective on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, October 20th. Finally, Wells Fargo & Company lowered their price objective on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $36.39.
Bath & Body Works Stock Up 0.1%
Shares of Bath & Body Works stock opened at $26.06 on Wednesday. Bath & Body Works, Inc. has a 52-week low of $24.85 and a 52-week high of $41.87. The company has a 50 day moving average of $27.35 and a 200 day moving average of $29.04. The company has a market capitalization of $5.37 billion, a P/E ratio of 7.73, a P/E/G ratio of 0.90 and a beta of 1.52.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the previous year, the firm earned $0.37 earnings per share. The firm’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s payout ratio is currently 23.74%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Drone Arms Race: From Battlefield to Balance Sheet
- EV Stocks and How to Profit from Them
- Why Wall Street Is Backing These 3 Comeback Stocks
- Following Congress Stock Trades
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
